Ignite Creation Date:
2025-12-24 @ 5:55 PM
Ignite Modification Date:
2026-05-20 @ 8:07 PM
Study NCT ID:
NCT01522768
Status:
COMPLETED
Last Update Posted:
2023-11-01
First Post:
2012-01-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
11-166
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None